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King Sau
osting by EAbstract Hydroxy propyl methyl cellulose (HPMC) 5cPs, an aqueous soluble polymer was
employed for coating diclofenac sodium (DFS) tablets 25 mg for protecting the integrity of the drug
yet rendering the drug to release at a faster rate on contact with the gastric environment. Proper
optimization for the aqueous based ﬁlm coating formulation was undertaken primarily employing
plasticizers like polyethylene glycol (PEG) 400 and propylene glycol (PG). The defect free selected
formulations were further subjected for studying the effects of surfactants like sodium lauryl sul-
phate (SLS) and Tween-80 along with the plasticizers. The quality of the aqueous ﬁlm coats or
the plasticizer efﬁciency in case of PEG-400 is in the order 1.5 > 0.5 > 1.0% and for PG
1 > 4 > 3% which can be stated on the basis of less incidence of major coat defects like chipping,
cracking, orange peel, roughness, blistering, blooming, picking. The quality of aqueous ﬁlm coat or
the surfactant efﬁciency in case of SLS + PEG-400 is in the order 0.3 < 0.5 < 0.1% and SLS +
PG is in the order 0.5 < 0.1 < 0.3%. In case of Tween-80 + PEG-400 the order is 0.3 <
0.5 < 0.1% and Tween-80 + PG is in the order 0.3 < 0.1 < 0.5%. Elegant ﬁlm formation can
be stated from fewer incidences of coat defects. The obtained coated tablets eventually satisﬁed
all the normal physical parameters like thickness, weights, and weight gain, drug content, crushing
strength, percent friability, disintegration time, dissolution proﬁle and possible drug–polymer inter-
actions. ANOVA was undertaken followed by Dunnet multiple comparison for the dissolution pro-
ﬁle considering uncoated as the standard. The difference was considered signiﬁcant at p 6 0.01.
ª 2009 King Saud University. All rights reserved..in (A. Roy).
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lsevier1. Introduction
Film coating is a complex process that involves different fac-
tors. To ensure spreading and/or ﬁlm forming capability plast-
icizers are added. The type and concentration of plasticizers can
affect the ﬁlm properties, as revealed by several investigations
(Mortada, 1990; Siepmann et al., 2005; James, 1997). The plas-
ticizing efﬁciency ismeasured by the lowering of the incidence of
Table 1 Characterization of the granules of F3B.
Parameters DFS granules
234 A. Roy et al.coat defects. In this study two plasticizers namely polyethylene
glycol 400 (PEG-400) and propylene glycol (PG) were selected.
Aqueous ﬁlm coating liquid was prepared by incorporating dif-
ferent concentrations of PEG-400 and PG (Mortada, 1990;
Muschert et al., 2009; Abdul-Razzak and Aulton, 1984).
As the viscosity of the coating solution increases, there is
greater resistance to spreading on the substrate surface and re-
duced tendency of the droplets to coalesce, both of which in-
crease surface roughness. Other factors arising from an
increase in solution viscosity, which may potentiate surface
roughness, include the larger mean droplet size on atomization
and the reduced penetration into the uncoated tablet or multip-
articulate surface (Siepmann et al., 2007; Felton, 2007; Herbert
et al., 1990). Variation in solution viscosity may also affect the
rate and extent that a coating formulation penetrates into a
substrate during the application. Difference in penetration
behavior may be important in determining the adhesion of
the coat to the substrate (James, 1997; Hossain and Ayers,
1990; Lippold et al., 1990). Little or no penetration may lead
to poor adhesion. Invariably a tablet formulation includes
lubricants to improve ﬂow properties of the granules and to
overcome certain processing problems. These ingredients are
hydrophobic and in ﬁne state of subdivision, present on the sur-
face of the tablet which may hinder penetration of the coating
liquid/solution. It is therefore prudent to include surfactants of
high HLB value at smaller concentration, to improve penetra-
tion and spreading properties of the coating liquid.
The objective was also to investigate the effects of surfactants
on the coating uniformity and quality of the ﬁlm coat. In this
study two surfactants of high HLB value such as sodium lauryl
sulphate (SLS) and Tween-80 were selected and incorporated at
different concentrations in the coating solutions (Mortada, 1990).
Diclofenac sodium (DFS), a phenyl acetic derivative, is an
NSAID, mainly used to treat different pain managements and
inﬂammation in various conditions; musculoskeletal and joint
disorders such as rheumatoid arthritis, osteoarthritis and anky-
losing spondilytis. DFS is also effective against peri-articular
disorders, soft tissue disorders and other painful conditions
such as renal colic, acute gout, dysmenorrhoea, migraine, and
surgical procedures. The usual dose of the drug is 75 to
150 mg orally or rectally. The terminal half-life of DFS is about
1 to 2 h. DFS at a low dose of 25 mg can also be formulated in
the form of immediate release tablets as an over the counter
(OTC)/non-prescription drug to counteract different pain man-
agements. This is due to the fact that DFS is the only salt that
has enough safety and pharmacovigilance data that supports
RX to OTC switch strategy (Moore, 2007; Rigato et al., 2009;
Motola et al., 2001). Coating of DFS is necessary to prevent
photolytic degradation and masking of its unpleasant taste.
Our present study is aimed in the preparation of a 25 mg
DFS tablet and subsequent development of an optimized ﬁlm
coating formula after properly studying the effects of plasti-
cizer and surfactants for the purpose of coating the tablets
(Motola et al., 2001; Morkhade et al., 2008).(starch + dicalcium phosphate)
Angle of repose () 28 ± 1.1
Bulk density (g/mL) 0.63
Tap density (g/mL) 0.78
Carr’s index 19.2 ± 0.5
Moisture content (%) 2.1 ± 1.1
All values represent mean ± SD (n= 3).2. Materials and methods
2.1. Chemicals
DFS was obtained from Roland Pharmaceuticals (Ganjam,
Berhampore, Orissa, India) as a gift sample. PEG-400, Propyl-ene glycol (PG), Dicalcium phosphate, SLS and Tween-80
were purchased from LOBA Chemie, Mumbai. HPMC 5 cps
and corn starch was purchased from Hi Media. Iso propyl
alcohol, talc, magnesium stearate and sodium hydroxide was
purchased from Merck. Titanium dioxide was purchased from
Qualigens. Hydrochloric acid was purchased from SD Fine
Chemicals. Fruit colors were purchased from Bush Chem.
All the chemicals and solvents were of analytical grade.
2.2. Preparation of the tablets
DFS tablets 25 mg were prepared by the process of wet gran-
ulation in a lab-scale wet granulator (Shakti Engneering, In-
dia) (Table 1). Required quantities of corn starch were mixed
with water gradually on a hot air oven until a semi-solid paste
was formed. This paste was treated as a binder and gradually
added to the granulator already containing the required quan-
tities of DFS and other excipients. The gralulator was operated
until a proper mix was obtained. The semisolid mix was passed
thorough sieve no. 10 and subjected to tray drying on a elec-
tronic tray drier (SAMS India Ltd., India). The dried granules
were collected and further passed through sieve no.16. Re-
quired quantities of talc, magnesium stearate and Aerosil were
added and subsequent punching of the tablets with 10 mm
biconcave punches on a 16-station rotary punching device
(Cadmach, India) (Table 2).
2.3. Procedure for the preparation of ﬁlm coating liquid involving
plasticizers
In a 500 ml clean beaker about 125 ml of puriﬁed water was
measured and the weighed amount of polymer HPMC 5 cps
was added and allowed to soak overnight. Next morning it
was stirred using a magnetic stirrer (Remi Motors, India) for
5–7 min to get a uniform dispersion of the polymer solution.
Other ingredients such as plasticizer, opaciﬁer, coloring agent
were added gradually in required quantities (Table 4). The
simultaneous evaluations are reported (Table 5). The selected
formulations F3 and F4 were further tried for the effect of
two surfactants namely SLS and Tween-80 and all the ingredi-
ents were added gradually in required quantities (Table 6). The
simultaneous evaluations are reported (Table 7).
2.4. Preliminary coating procedure
Two hundred tablets of DFS were loaded on a lab-scale pan
coater (SAMS Ltd., India) previously cleaned, dedusted. The
coating liquid was ﬁlled into the spray gun with pneumatic
pump attachment (Suguna Pneumatics, India). The pan was
Table 2 Composition of DFS tablet.
Composition Purpose Quantity for 1 tablet (mg)
Diclofenac sodium API (active pharmaceutical ingredient) 25
Corn starch (paste) Binder 55
Dicalcium phosphate Exepients 166
Corn Starch (dried) Disintegrant 40
Aerosil Flow promoter 3.5
Magnesium stearate Lubricant 7
Talc Glidant 3.5
Total weight 300
Table 3 The different adjusted process variables.
Process variables Adjusted speciﬁcations
Pan design/baﬄing 12 feet diameter with no baﬄes
Rotational speed of pan 40 rpm
Spray pressure (operational) 60–70£ per square inch (p.s.i)
Bed to gun distance 1–1.5 feet
Bed temperature 30 ± 5 C
Dry air temperature 60 ± 5 C
Spray pattern type Circular, occasionally elliptical
Pan load 70 gm
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All the parameters were previously adjusted with dummy tab-
lets (Table 3). As the tablets rolled, the ﬁlm forming liquid was
sprayed intermittently allowing the solvent to evaporate. The
process was continued until all the coating solution was used
up (Muschert et al., 2009; Abdul-Razzak and Aulton, 1984;
Siepmann et al., 2007; Bodmeier and Paeratakul, 1989).
2.5. Determination of different evaluatory parameters for the
prepared aqueous coated tablets
The selected coated tablets were evaluated for their thickness,
weights, weight gain, drug content, diametral crushing
strength, percent friability, disintegration time, dissolution
proﬁle, and drug–polymer interactions.
2.6. Tablet weight gain
Six coated tablets were randomly selected from each batch and
the weight was determined individually in an electronic bal-
ance (Sartorius, India). The average weight of 6 tablets was
calculated. The difference in the average weight with respect
to the average weight of the uncoated tablet gave the weight
gain of the coated tablet and the percentage weight gain was
calculated accordingly and reported (Table 8).Table 4 Formula for ﬁlm coating formulations involving plasticize
Ingredients F1 (%) w/w F2 (%) w/w F
HPMC 7.5 7.5 7
PEG-400 0.5 1.0 1
Plasticizer (PG) – – –
Colorants 0.6 0.6 0
Opaciﬁer (titaniumdioxide) 3 3 3
Puriﬁed water q.s q.s q2.7. Film thickness measurements (Bodmeier and Paeratakul,
1989)
Six coated tablets were randomly selected from each batch and
the thickness was measured individually using a slide calipers.
The difference in the thickness with respect to the uncoated
tablet gave the coat thickness. The cast ﬁlm thickness measure-
ment was done by using a ﬁlm thickness tester (Baker dial
gauge-type J17, India) by peeling off the adhering ﬁlms from
the substrate surface. Uniformity in thickness was measured
by selecting four different zones of the cast ﬁlms. The average
of each formulation is noted (Table 8).
2.8. Disintegration test (Morkhade et al., 2008)
Disintegration tester (Campbell Electronics, India) was used to
determine the resistance or disintegration time of the selected
ﬁve aqueous ﬁlm-coated tablets. Six tablets were randomly se-
lected from each batch and one tablet was placed in each of the
six tubes. The basket rack was positioned in a 1 l beaker of
0.1(N) HCl at 37 ± 0.5 C. Perforated auxiliary discs were
placed on the top. The instrument was operated and the time
taken for a tablet to disintegrate and all the particles to pass
through the no.10 USP mesh aperture was noted according
to USP/NF/IP until a palpable mass remains. The average
time is reported (Table 8).
2.9. In vitro release studies (Morkhade et al., 2008; Fulzele
et al., 2002; Ghosh et al., 2007)
The release measurements were performed using 8 stage USP
dissolution apparatus-1 (Disso-2000, Lab India). The dissolu-
tion parameters (one tablet; 37 ± 0.5 C; 100 rpm; 900 ml of
0.1(N) hydrochloric acid). A single tablet from the chosen for-
mulation was placed in the basket and 5 ml of aliquots were
withdrawn at suitable intervals up to 1 h 30 min. The samples
were assayed spectrophotometrically using UV–VIS doublers.
3 (%) w/w F4 (%) w/w F5 (%) w/w F6 (%) w/w
.5 7.5 7.5 7.5
.5 – – –
1 2 3
.6 0.6 0.6 0.6
3 3 3
.s q.s q.s q.s
Table 5 Visual observation for defects in the formulations containing plasticizers.
Defects F1 F2 F3 F4 F5 F6
Blistering ++ – – – – –
Blooming +++ – – – ++ +
Chipping +++ +++ + ++ +++ ++
Cracking ++ – – – – –
Orange peel – +++ – – – –
Picking – +++ – – ++ –
Roughness ++ +++ ++ – ++ ++
Splitting +++ ++ + + +++ +
Thickness of cast ﬁlm (mm) 0.2 0.3 0.2 0.1 0.2 0.2
Weight gain (%) 25 23.64 21.62 10.13 18.24 21.62
Yes (+++), no (–), slight (++), very slight (+).
Table 6 Formula for ﬁlm coating involving plasticizers and surfactants.
Ingredients F3A
(%) w/w
F3B
(%) w/w
F3C
(%) w/w
F4A
(%) w/w
F4B
(%) w/w
F4C
(%) w/w
F3D
(%) w/w
F3E
(%) w/w
F3F
(%) w/w
F4D
(%) w/w
F4E
(%) w/w
F4F
(%) w/w
HPMC 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5 7.5
PEG-400 1.5 1.5 1.5 – – – 1.5 1.5 1.5 – – –
Plasticizer (PG) – – – 1.0 1.0 1.0 – – – 1.0 1.0 1.0
Opaciﬁer (titanium dioxide) 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0 3.0
Surfactants (SLS) 0.1 0.3 0.5 0.1 0.3 0.5 – – – – – –
Tween-80 – – – – – – 0.1 0.3 0.5 0.1 0.3 0.5
Colorants 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6 0.6
Puriﬁed water q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s q.s
Table 7 Visual observation for defects in the formulations containing plasticizers and surfactants.
Defects F3A F3B F3C F4A F4B F4C F3D F3E F3F F4D F4E F4F
Blistering +++ – – +++ – – – – – – – –
Blooming – – ++ ++ – – +++ + – ++ ++ ++
Chipping +++ – – +++ – ++ – +++ ++ ++ – ++
Cracking – – – – – – – – – – – +++
Orange peel – – – ++ +++ – +++ – – – – ++
Picking – – – – +++ – – – – – – –
Roughness ++ – ++ ++ +++ – +++ ++ – – – +++
Splitting ++ – +++ – – ++ – +++ ++ ++ – +++
Thickness of cast ﬁlm (mm) 0.33 0.23 0.30 0.30 0.40 0.30 0.33 0.23 0.10 0.10 0.10 0.30
Weight gain (%) 23.64 21.62 25.15 22.63 18.24 23.64 18.24 22.63 23.64 20.13 22.63 25.10
Yes (+++), no (–), slight (++), very slight (+).
Table 8 Evaluatory parameters for uncoated and selected coated tablets of DFS.
Parameters Uncoated F3B F4E F4 F3 F4C
Thickness (mm) 5.5 5.7 5.7 5.6 5.7 5.8
Cast ﬁlm thickness – 0.2 0.21 0.15 0.2 0.33
Weights (mg) 300.0 340.0 342.5 340.5 345.0 350.0
Diametral hardness (kg/cm2) 4.8 5.2 5.3 5.1 5.4 5.4
Friability (%) 0.34 0.03 0.10 0.08 0.06 0.04
Disintegration time 2 min 20 s 2 min 30 s 3 min 2 s 2 min 40 s 2 min 55 s 3 min 10 s
Weight gain (%) 0 13.33 14.16 13.5 15.0 16.66
Assay (%) 98.24 98.74 98.16 95.85 97.66 94.92
236 A. Roy et al.beam spectrophotometer (Elico, India) at 276 nm. The data for
percent drug release was ﬁtted for zero order equation. Thepercent of drug release was determined as a function of time
(Fig. 2).
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The signiﬁcance of difference between the dissolution of differ-
ent studied formulations considering uncoated formulation as
the standard was evaluated using the analysis of variance (AN-
OVA) followed by Dunnett multiple comparison test. The dif-
ference was considered signiﬁcant at p 6 0.01. These statistical
calculation were performed using Graph pad Instant computer
program (September 11, 2003; Graph Pad Software, San Die-
go, CA).
2.11. Fourier transform infrared spectra (FT-IR) (Ghosh et al.,
2007; Wang et al., 2008)
Infrared spectra of the pure drug, uncoated DFS tablets and
HPMC coated DFS tablets dispersed in KBr were recorded
on a FT-IR spectrophotometer (Model-FT-IR 8400S, SHI-
MADZU, Japan). The disc method was employed to study
the possible interactions between the drug and the selected
polymer HPMC (5cPs). KBr (IR Grade) discs in a proportion
of 1:100:sample:KBr, were prepared from the samples and
eventually analyzed over a range of 400–4000 cm1. Transmit-
tance (T) spectra were recorded and displayed in an overlay
mode (Fig. 1).
2.12. Scanning electron microscopy
Tablet samples (F3B) were removed from dissolution appara-
tus at predetermined time intervals (0, 30 min, 1 h) and ﬁlms
were scrapped off by sectioning transversally from the concave
face of the tablet. The specimen was then placed on a sample
holder so as to present surface and cross sectional view of
the tablet to the microscope. Samples were coated with goldFigure 1 FT-IR overlay spectra of both coand visualized under scanning electron microscope (SEM)
(JEOL, JSM 840A, Japan) (Fig. 3).3. Results and discussion
The tablets were prepared in an environment free from organic
solvents. From the results it can be stated that plasticizers like
PEG-400 at 1.5% and PG at 1% have a signiﬁcant effect on
the ﬁlm forming property of HPMC. The ﬁlms formed with
HPMC+ PEG400 (1.5%) were free from major defects like
cracking, orange peel, and picking with good gloss and very
slight chipping and splitting occasionally (Mortada, 1990;
James, 1997; Hossain and Ayers, 1990). In regard to
HPMC+ PG (1%) the resultant ﬁlms were free from defects
such as roughness, picking, orange peel and cracking, having
good gloss and slight chipping. Uniformity in tablet weight
gain and thickness of the ﬁlm coat data obtained from cast ﬁlm
measurements are supportive for elegant ﬁlm formation. The
quality of aqueous ﬁlm coat or the plasticizer efﬁciency in case
of PEG-400 is in the order 1.5 > 0.5 > 1.0% and for PG
1 > 4 > 3%. This preliminary study infers that plasticizer sig-
niﬁcantly inﬂuences the quality of aqueous ﬁlm coats. The best
formulations (F3 and F4) are selected for further trials. Two
surfactants of high HLB value namely SLS and Tween-80 were
tried for bringing uniformity in the spreading efﬁciency on the
substrate surface. It was found out that among the six formu-
lations containing SLS, F3B (HPMC+ PEG 1.5%+ SLS
0.3%) yielded the most satisfactory result. The ﬁlms were
found to be free from blistering, blooming, chipping, cracking,
picking, orange peel, roughness, splitting with uniform color
distribution and good glossy appearance. On the other hand
with the six formulations of Tween-80, F4E (HPMC+
PG1.0%+ Tween-80 0.3%) yielded the most satisfactoryated and uncoated formulations of DFS.
Figure 2 Dissolution proﬁles of coated and uncoated formulations of DFS in 0.1(N) HCl.
Figure 3 Scanning Electron (SEM) photomicrographs of HPMC 5cPs coated DFS tablets (F3B) showing surface morphology after 0 h
(A, 500·), 30 min (B, 500·), 30 min (C, 2000·) of dissolution study (in A and B, arrow indicates the formation of pores on coated surface,
C indicates eruption and leaching of drug).
238 A. Roy et al.result. The ﬁlms were found to be free from blistering, chip-
ping, cracking, picking, orange peel, roughness, splitting with
slight blooming, uniform color distribution and good glossy
appearance. The quality of aqueous ﬁlm coat or the surfactant
efﬁciency in case of SLS + PEG-400 is in the order
0.3 < 0.5 < 0.1% and SLS + PG is in the order 0.5 <0.1 < 0.3%. In case of Tween-80 + PEG-400 the order is
0.3 < 0.5 < 0.1% and Tween-80 + PG is in the order 0.3 <
0.1 < 0.5%. From this study it may be concluded that surfac-
tants of high hydrophilic nature might be useful in improving
the ﬁlm coating liquid properties to achieve better spreading
and resulting in better quality ﬁlm coats.
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repose, moisture content, and bulk density was found to be
normal within the acceptable limits stated in Table 1. Evalu-
atory parameters of the coated tablets like thickness, weight,
diametral hardness, and friability were found to be within
the normal limits as stated in Table 8.
The total disintegration time of all the selected tablets was
found to be within 2 min 30 s (F4B) to 3 min 30 s compared to
the uncoated 2 min 20 s in 0.1(N) HCl. This suggests that there
is no abnormality for the drug to disintegrate in its speciﬁed
environment.
The in vitro release data of all formulations were ﬁtted in
zero order and the rate constants and correlation coefﬁcient
were compared to get a trend in the release pattern of the drug
from the formulations. From Fig. 2 it is evident that the se-
lected batches F4B and F4E predominantly shows a zero order
proﬁle releasing the DFS within 1 h 30 min which eventually
satisﬁes the percentage release. The initial bursting effect of
the ﬁlm coats was obtained in between a time span of 5 min
and leaching of the API was observed. The cumulative percent
release within 5 min after examination was found out to be in
the order F4B > F4E > F4 > F3 > F4C which suggests the
proper functioning of the ﬁlms.
From the infrared spectra Fig. 1 it is clearly evident that
there were no interactions of the drug with the polymer. The
main peaks in the spectrum of the drug DFS, both uncoated
and coated does not show any substantial difference. The IR
spectra show a peak at 746.18, which signiﬁes the presence
of N–H (rocking) functional group. A peak is also observed
at 1651.12 wave number, which signiﬁes the presence of C–C
(stretch). Simultaneously a peak at 746.48 signiﬁes the presence
of C–Cl (stretch). All these peaks were observed at the ﬁnger-
print region of the FT-IR spectra. This proves the fact that
there is no potential incompatibility of the drug with the poly-
mer (HPMC 5cPs) used in the formulations. Hence, the for-
mula for preparing DFS (25 mg) coated with HPMC 5cPs
tablets can be reproduced in an industrial scale without any
apprehension of possible drug–polymer interactions.
SEM study further conﬁrmed the proper erosion and diffu-
sion mechanisms to be operative during drug release from the
optimized batch of HPMC 5cPs coated DFS tablet (F3B).
SEM photomicro-graphs of the tablets at different time inter-
vals after the dissolution experiment showed that tablets were
intact and pores had formed through the surface (Fig. 3). Pho-
tomicrographs from SEM at deﬁnite time intervals 0, 30 min,
(A, B) revealed pores with increasing diameter. The photomi-
cro-graphs also revealed formation of gelling structure (C)
indicating the possibility of swelling and eroding of the tablets.4. Executive summary
In conclusion, tablet coating ﬁlms made of HPMC 5cPs with
the addition of PEG at 1.5% and SLS at 0.3% and ﬁlms made
of HPMC 5cPs with PG at 1% and Tween-80 at 0.3% could be
considered as an elegant ﬁlm forming formulation for solving
different coating problems generally faced in an industrial
scale. The ﬁlm coating formulations were entirely prepared
in an aqueous environment avoiding the environmental un-
friendly toxic hazards accompanied with organic solvents.
These optimized formulations could be further developed in
an industrial scale for the purpose of coating immediate releaseformulations for those drugs whose integrity needs to be pro-
tected from sunlight, oxidations, moisture, thermolability and
foreign microbial attack. The concept of Rx to OTC switch
strategy (Moore, 2007; Rigato et al., 2009), for the proven saf-
est salt of diclofenac can be eventually satisﬁed by the use of
such selected formulations for the purpose of coating.Acknowledgements
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